These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 15689299

  • 1. A case-control study of HIV-associated pancreatic abnormalities during HAART era. Focus on emerging risk factors and specific management.
    Manfredi R, Calza L, Chiodo F.
    Eur J Med Res; 2004 Dec 22; 9(12):537-44. PubMed ID: 15689299
    [Abstract] [Full Text] [Related]

  • 2. HIV infection and the pancreas: risk factors and potential management guidelines.
    Manfredi R, Calza L.
    Int J STD AIDS; 2008 Feb 22; 19(2):99-105. PubMed ID: 18334062
    [Abstract] [Full Text] [Related]

  • 3. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, Liñares J, Gudiol F, Spanish Pneumococcal Infection Study Network (G03/103).
    Arch Intern Med; 2005 Jul 11; 165(13):1533-40. PubMed ID: 16009870
    [Abstract] [Full Text] [Related]

  • 4. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V, Ponce-de-León S, Anaya-Saavedra G, Crabtree Ramírez B, Sierra-Madero J.
    Clin Infect Dis; 2007 Oct 01; 45(7):925-32. PubMed ID: 17806063
    [Abstract] [Full Text] [Related]

  • 5. Prolonged statin administration does not act on the cell-mediated immunity of HIV-infected dyslipidemic patients treated with a steady and effective highly active antiretroviral therapy. A two-year prospective study of statin versus fibrate administration.
    Manfredi R, Calza L, Chiodo F.
    J Biol Regul Homeost Agents; 2006 Oct 01; 20(1-2):1-9. PubMed ID: 18088548
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.
    Infection; 2005 Oct 01; 33(5-6):345-9. PubMed ID: 16258865
    [Abstract] [Full Text] [Related]

  • 8. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
    Young J, Rickenbach M, Weber R, Furrer H, Bernasconi E, Hirschel B, Tarr PE, Vernazza P, Battegay M, Bucher HC.
    Antivir Ther; 2005 Oct 01; 10(1):73-81. PubMed ID: 15751765
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY, Terrin N, Wanke C, Skinner S, Tchetgen E, Shevitz AH.
    Clin Infect Dis; 2005 Dec 01; 41(11):1662-70. PubMed ID: 16267741
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
    Napravnik S, Keys JR, Quinlivan EB, Wohl DA, Mikeal OV, Eron JJ.
    AIDS; 2007 Apr 23; 21(7):825-34. PubMed ID: 17415037
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006.
    Smyth K, Affandi JS, McArthur JC, Bowtell-Harris C, Mijch AM, Watson K, Costello K, Woolley IJ, Price P, Wesselingh SL, Cherry CL.
    HIV Med; 2007 Sep 23; 8(6):367-73. PubMed ID: 17661844
    [Abstract] [Full Text] [Related]

  • 16. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida.
    Enferm Infecc Microbiol Clin; 2009 Apr 23; 27(4):222-35. PubMed ID: 19246124
    [Abstract] [Full Text] [Related]

  • 17. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC.
    HIV Med; 2006 Mar 23; 7(2):99-104. PubMed ID: 16420254
    [Abstract] [Full Text] [Related]

  • 18. Distal sensory polyneuropathy in HIV-positive patients in the HAART era: an entity underestimated by clinical examination.
    Skopelitis EE, Kokotis PI, Kontos AN, Panayiotakopoulos GD, Konstantinou K, Kordossis T, Karandreas N.
    Int J STD AIDS; 2006 Jul 23; 17(7):467-72. PubMed ID: 16820077
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy.
    Fernández Guerrero ML, Rivas P, Molina M, Garcia R, De Górgolas M.
    Clin Infect Dis; 2005 Aug 01; 41(3):390-4. PubMed ID: 16007538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.